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Background: When using a pulsatile left ventricular assist device (LVAD), it is
important to reduce the cardiac load variations of the native heart because severe
cardiac load variations can induce ventricular arrhythmia. In this study, we
investigated the effect of counter-pulsation control of the LVAD on the reduction of
cardiac load variation.
Methods: A ventricular electrocardiogram-based counter-pulsation control algorithm
for a LVAD was implemented, and the effects of counter-pulsation control of the
LVAD on the reduction of the working load variations of the left ventricle were
determined in three animal experiments.
Results: Deviations of the working load of the left ventricle were reduced by 51.3%,
67.9%, and 71.5% in each case, and the beat-to-beat variation rates in the working load
were reduced by 84.8%, 82.7%, and 88.2% in each ease after counter-pulsation control.
There were 3 to 12 premature ventricle contractions (PVCs) before counter-pulsation
control, but no PVCs were observed during counter-pulsation control.
Conclusions: Counter-pulsation control of the pulsatile LVAD can reduce severe cardiac
load variations, but the average working load is not markedly affected by application of
counter-pulsation control because it is also influenced by temporary cardiac outflow
variations. We believe that counter-pulsation control of the LVAD can improve the
long-term safety of heart failure patients equipped with LVADs.
Keywords: Left ventricular assist device, Counter-pulsation control, Left ventricle
working load, Ventricular electrocardiogramBackground
When a pulsatile left ventricular assist device (LVAD) is used to support the blood pump-
ing function of the damaged native heart of a patient in end-stage heart failure, it is im-
portant to consistently supply sufficient blood flow to the aorta [1-3]. Furthermore, it is
important to reduce the variations in the physical load of the left ventricle (LV) during
LVAD support because severe cardiac load variations can shorten the monophasic action
potential duration of repolarization of the native heart (QT interval), thus increasing the
risk of ventricular tachycardia or fibrillation [4-9]. Most pulsatile LVAD systems are con-
nected to the LV and the aorta in parallel, allowing for simultaneous blood pumping by© 2014 Choi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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can generate temporary severe cardiac load variations that can threaten long-term patient
safety. To reduce the risk of LVAD support, the incidence of these temporary severe car-
diac load variations must be reduced. This can be realized by counter-pulsating control of
the LVAD, which prevents the simultaneous co-pulsation of the native heart and the
LVAD [10].
Several studies have investigated the relationship between the control scheme of the
LVAD and the working load of the native heart. For example, Shi et al. assessed the
hemodynamic benefits of three pumping modes (constant, counter-pulsation, and co-
pulsation) using a diseased cardiovascular model and three VAD models (positive dis-
placement, impeller, and a novel reciprocating-valve design) [11]. In their study, the
working load of the LV was lower using the displacement pump and the reciprocating-
valve pump in counter-pulsation mode. In addition, Lim et al. implemented a deadbeat
controller that could operate an implantable rotary blood pump in a pulsatile manner
using pump speed and driver current measurements [12]. In their simulation using
in vivo porcine model data and in vitro mock loop data, counter-pulsation produced
minimal stroke work and LV end-diastolic volume compared with other control
schemes. These simulation studies demonstrated the benefits of counter-pulsation con-
trol of the LVAD, but neither performed animal experiments to identify the actual ef-
fects of counter-pulsation control on the working load of the native heart. Therefore,
although these previous simulation studies mathematically proved the benefit of
counter-pulsation control of the LVAD, it is also worth observing the actual effects of
counter-pulsation control on the working load of the native heart using animal models.
In this study, the clinical effects of counter-pulsation control of the pulsatile LVAD
on the reduction in working load variations of the LV during LVAD support were eval-
uated in an animal model.Methods
Brief description of the pneumatic LVAD used
This study utilized a portable pneumatic LVAD, the LibraHeart I, which is under devel-
opment by the Kangwon National University and LibraHeart Inc. (Chuncheon, Korea)
[13-15]. It comprises three sub-parts: 1) a portable pneumatic driver comprising a
brushless DC motor, a ball screw, a piston, and a cylinder; 2) an implantable blood
pump comprising a diaphragm, inlet and outlet cannulae, two one-way valves, and two
unipolar leads and platinum plates on the surface of the inlet and output cannulae; and
3) an air duct with two solenoid one-way air valves (Figure 1a). It was designed such
that the maximal outflow is ≥ 5 L/min, the one-stroke volume is 50 mL, and the max-
imal pumping rate is 120 bpm. The implantable blood pump was designed to be a
bent-tube shape to reduce its own flow resistance. The inlet cannula of the blood pump
is connected to the LV apex of the native heart, and the outlet cannula of the blood
pump is connected to the aorta. When the pneumatic driver begins operating, an outlet
air valve on the air duct is closed, and the pneumatic pressure in the air duct is then
manually adjusted via an inlet air valve on the air duct so that the blood pump operates
in full-filling and full-ejection states. Figure 1b demonstrates the operating mechanism
of the LibraHeart I under normal situations (left) and in the power-off situation (right).
Figure 1 LibraHeart I pulsatile LVAD system (a) and its operating mechanism under normal
situations (left) and in the power-off situation (right) (b).
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blood-pumping function of the damaged native heart: solid lines in the blood pump (dia-
phragm and valve) represent blood ejection and dashed lines represent blood-filling pe-
riods of the LVAD, respectively. When the operation of the pneumatic driver is stopped
due to an unpredicted system malfunction or other emergency situation during long-term
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valve on the air duct is opened and pneumatic pressure in the air duct decreases (power-
off situation). The blood sac is then maximally enlarged by the LV ejecting force; that is,
the blood pump serves as a hollow bent tube and plays the role of a secondary blood path
between the LV and the aorta. Thus, the contraction force of the LV can maintain a certain
volume of blood flow through the pump, even after the pneumatic driver has stopped if
both cannulae are short. In this way, thrombus formation in the blood sac is delayed, and
if the operator replaces the pneumatic driver and begins re-operation within a short time
interval, the damage to the patient can be reduced.Implementation of counter-pulsation control
To measure the ventricular electrocardiogram (v-ECG) signals in a real-time manner using
two unipolar leads, platinum plates were fixed onto the surface of the inlet and outlet can-
nulae of the implantable blood pump [16]. These plates were connected to the controller
board in the pneumatic driver console through wire connections. During implantation, the
tip of the measuring electrode was fixed to the LV apex, and the tip of the reference elec-
trode was fixed to the ascending aorta by suturing. The measured v-ECG signal was con-
verted into QRS peak signals, which represent the timing of LV contraction, using the
following signal processing techniques: band-pass filtering, differentiation, integration, and
threshold comparing (Figure 2) [17,18]. More specifically, first, the measured v-ECG signal
passed a band-pass filter (lower cut-off frequency = 0.1 Hz and higher cut-off frequency =
50 Hz) to eliminate offset and high-frequency noise components; second, the filtered signal
was differentiated and the signal part with negative differential value (Diff in Figure 2a) was
extracted from the filtered v-ECG signal; third, the value of the accumulator (A in Figure 2a)
was increased by Diff when the sign of the Diff was negative or was cleared to zero when
the sign of the Diff was not negative; and fourth, when the value of the accumulator exceeds
a preset threshold value (1 mV), the implemented algorithm determines the wave as a QRSFigure 2 v-ECG-based QRS peak detection algorithm implemented for LibraHeart I (a) and signal
patterns before, during, and after peak detection processing (b). Thr: threshold.
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prevent co-pulsation between the native heart and the LibraHeart I. Table 1 shows the ac-
curacy of the implemented QRS peak detection algorithm based on the v-ECG signal. It
showed high (>95%) accuracy in all experiments.
Animal experiments
Animal experiments using three pigs weighing 35.2 to 40.1 kg were performed with the
approval of the Institutional Review Board of Kangwon National University and in
compliance with the Ethics and Regulations for Animal Study. The animals were laid
on the operating table in a supine position, and 10 mg/kg of intramuscular ketamine
was injected to induce anesthesia. Anesthesia was maintained during the surgical pro-
cedure and the sensor signal-monitoring period after device operation by consistently
supplying 1 – 2% inhaled isoflurane through an endotracheal tube. The inlet cannula
was connected to the LV apex, and the outlet cannula was connected to the ascending
aorta through a median sternotomy. Table 2 shows the animal characteristics before
and during application of the LVAD. In all experiments, the animals survived for 3 h
after starting the LVAD operation, and then were euthanized by an anesthetic overdose.
Three additional electrodes were attached to both forelegs and the left rear legs of the
animals to compare the v-ECG measurements with those of conventional ECG, and the
arterial blood pressure (ABP) was measured at the carotid artery. To calculate the
working loads of the LV and the LVAD before and after application of the counter-
pulsation control, cardiac outflow and LVAD outflow were monitored using two ultra-
sonic flowmeters (T109 for LVAD and T106 for LV; Transonic Systems Inc., NY, USA;
the manufacturer guaranteed error rates under 10% at 36.7° blood condition for both
devices). The probe for cardiac outflow measurement was attached to the aortic arch,
and the probe for LVAD outflow measurement was attached to the outlet cannula. The
working loads (WLs) of the animal’s LV and LVAD were calculated using Eq. (1):
WL Joule=beatð Þ ¼
Z t1
t0
F tð Þ  P tð Þð Þdt ð1Þ
where t0 represents the starting time of heart contraction and t1 the ending time of
heart contraction. F(t) represents the blood flow through the aortic valve when calcu-
lating the LV load and the blood flow through the outlet valve of the LVAD when cal-
culating the LVAD load, respectively. P(t) commonly represents the aortic pressure of
the animal in both cases.
In this study, we substituted the aortic pressure in Eq. (1) with the ABP measurements
at the carotid artery because measuring the aortic pressure directly during the experi-
ments was difficult. Carotid artery is placed near the aortic valve and is also directlyTable 1 Accuracy of the implemented v-ECG-based QRS peak detection algorithm during
animal experiments
Animal (dur.) Occurred QRS peak Missed QRS peak Accuracy
1 (40 min) 3,957 39 99.0%
2 (60 min) 4,501 75 98.3%
3 (25 min) 1,826 61 96.7%
dur time duration of peak number counting.
Table 2 Animal characteristics before and during application of the LVAD
Animal Weight (kg) Before LVAD application During LVAD application
ABP (S/M/D) (mmHg) Mean HR (bpm) ABP (S/M/D) (mmHg) Mean HR (bpm)
1 37.4 65/47/38 84.1 55/46/41 90.1
2 40.1 54/37/30 73.8 48/42/39 89.0
3 35.2 87/59/46 102.3 90/58/40 97.7
ABP arterial blood pressure, S systole, M mean, D diastole, HR heart rate.
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very similar to the aortic pressure. In addition, to observe the variation in the working
load of the LV and LVAD during blood pumping before and after application of counter-
pulsation control, the beat-to-beat variation rate in the working load (load variation rate,
LVR) was calculated using Eq. (2):




where WLprevious represents the previously calculated working load and WLpresent rep-
resents the present calculated working load, respectively.
Results
During the experiments, the total aortic outflow of the animals was maintained in the
range 3.3 – 3.7 L/min, and the heart rate of the animals did not vary substantially be-
fore and after LVAD implantation because the animals were under anesthesia. The car-
diac outflow was reduced from 3.3 – 3.7 to 1.8 – 2.3 L/min after LVAD implantation;
therefore, the pumping rate of the LVAD was set to 70 bpm before counter-pulsation
control to regulate the LVAD outflow in the range 1.4 – 1.7 L/min, and was adjusted to
100 bpm to regulate the LVAD outflow in the range 1.5 – 1.9 L/min during counter-
pulsation control to maintain the total aortic flow at 3.3 – 3.7 L/min during LVAD sup-
port. Figure 3 shows the ABP, outflow of the LVAD, and QRS peaks of v-ECG and ECG
signals before and during counter-pulsation control in the first experiment. As seen in
Figure 3, co-pulsation between the native heart and the LVAD was successfully pre-
vented and the LVAD outflow pattern was better stabilized after counter-pulsation con-
trol (the variation between each ABP pulse signal was reduced, especially at the fourth,
eighth, tenth and tenth pulses in Figure 3a).Figure 3 ABP, LVAD outflow, and QRS peaks of v-ECG and ECG signals before (a) and during (b)
counter-pulsation control.
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fore and during counter-pulsation control in all experiments, and Figure 4 shows the
beat-to-beat working load variations in the LV and LVAD during 110 successive blood
pumping periods before and during counter-pulsation control in the first experiment.
As shown in Table 3, the standard deviations of the LV load were reduced from 0.113
to 0.055 Joules/beat (51.3% reduction) in Case 1, from 0.106 to 0.034 Joules/beat
(67.9% reduction) in Case 2, and from 0.123 to 0.035 Joules/beat (71.5% reduction) in
Case 3 during counter-pulsation control. The LVR values were also reduced from
64.5% to 9.8% (84.8% reduction) in Case 1, from 60.0% to 10.4% (82.7% reduction) in
Case 2, and from 73.7% to 8.7% (88.2% reduction) in Case 3 during counter-pulsation
control. On the contrary, the working load of the LV was reduced in Cases 1 and 3, but
was increased in Case 2 during counter-pulsation control.
Table 4 shows the heart rate variations and occurrences of premature ventricle contrac-
tions (PVCs) before and during counter-pulsation control (each sample was of 5-min dur-
ation). Heart rate variations were reduced from 101.4 ± 13.6 to 90.8 ± 1.3 bpm in Case 1,
from 80.5 ± 13.8 to 90.1 ± 1.0 bpm in Case 2, and from 102.8 ± 11.4 to 98.7 ± 1.2 bpm in
Case 3 during counter-pulsation control. There were 3 to 12 PVCs before counter-
pulsation control, but no PVCs were observed during counter-pulsation control.
Before counter-pulsation control, the working load of the LV in the diastole phase
varied under 85% of the average working load of the LV (p-value < 0.05), but during
counter-pulsation control, this working load variation in the diastole phase reduced to
under 35% of the average working load (p-value < 0.05). In addition, most of the LVR
values were over 4% before counter-pulsation control (p-value < 0.05) and were under
20% during counter-pulsation control (p-value < 0.05).Discussion
In this study, a counter-pulsation algorithm for a pneumatic LVAD was implemented, and
the clinical effects of counter-pulsation control on the working load of the native heart
were evaluated in three short-term animal experiments. In the animal experiments, the
mean values of the working load of the LV were not markedly affected by counter-
pulsation control (e.g., the working load of the LV decreased during counter-pulsation
control in Cases 1 and 3, but increased during counter-pulsation control in Case 2). This
occurred because the working load of the LV is affected by temporary variations in cardiac
outflow and aortic pressure; therefore, if the cardiac outflow is temporarily increased, the
working load of the native heart can increase even when the aortic pressure is actually re-
duced by counter-pulsation control. On the contrary, the deviations in the working loadTable 3 Variations in the working load and LVR values in the LV before and during
counter-pulsation control
Animal Load of LV (Joules/beat) LVR of LV (%) LV load
reduction (%)Before During Before During
1 0.258 ± 0.113 (n = 115) 0.238 ± 0.055 (n = 113) 64.5 (n = 114) 9.8 (n = 112) 7.6
2 0.273 ± 0.106 (n = 130) 0.318 ± 0.034 (n = 130) 60.0 (n = 129) 10.4 (n = 129) −16.5
3 0.216 ± 0.123 (n = 120) 0.148 ± 0.035 (n = 120) 73.7 (n = 119) 8.7 (n = 119) 31.5
Data are presented as means ± standard deviation format.
Figure 4 Variations in beat-to-beat working loads of the LV and LVAD before (a) and during (b)
counter-pulsation control in the first experiment.
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tion), as were LVR values (82.7 – 88.2% reduction). These results suggest that counter-
pulsation control of the LVAD reduces the maximal deviation of the cardiac load and
therefore also the occurrence of temporary severe cardiac load variations.
The occurrence of ventricular arrhythmia during VAD support is a topic of debate.
For example, in studies by Moroney et al. [19] and Arai et al. [20], the frequency of the
occurrence of ventricular arrhythmia during VAD support was reduced after VAD sup-
port, but ventricular arrhythmias during VAD support were temporary and converted
spontaneously to normal pacing; the effect on patient survival was not significant. On
the contrary, Harding et al. reported that LVAD placement induces changes in the con-
tractile function of the failed native heart, and the early period after initiation of LVAD
support of the failed native heart is associated with a relatively high incidence of signifi-
cant ventricular arrhythmias after LVAD placement [21,22]. In addition, Brenyo et al.
reported that the patient’s pre-LVAD history of ventricular arrhythmia is a significant
predictor of the occurrence of post-LVAD ventricular arrhythmia, and the occurrenceTable 4 Heart rate variations and PVC occurrences before and during counter-pulsation
control
Animal Heart rate PVC
Before During Before During
1 101.4 ± 13.6 90.8 ± 1.3 7 (n = 115) 0 (n = 113)
2 80.5 ± 13.8 90.1 ± 1.0 3 (n = 130) 0 (n = 130)
3 102.8 ± 11.4 98.7 ± 1.2 12 (n = 120) 0 (n = 120)
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particularly within the first month [23]. Furthermore, to enhance the survival rate of
LVAD patients, Refaat et al. [24] and Cantillon et al. [25] implanted a cardioverter-
defibrillator with a LVAD, and Dandamudi et al. [26] performed catheter ablation to
resolve ventricular tachycardia in VAD patients. Our findings demonstrate that
LVAD counter-pulsation control can stabilize the blood pumping of the native heart
and prevent the temporary severe cardiac load variations that may induce ventricular
arrhythmias during LVAD support; e.g., the heart rate variations were reduced from
11.4 – 13.8 to 1.0 – 1.3 bpm during counter-pulsation control. In addition, PVCs
were eliminated during counter-pulsation control. These experimental results dem-
onstrate that the application of counter-pulsation control can seriously reduce the
occurrence of abnormal heart beats during LVAD support without any additional
surgical operations. Considering this result, it may be recommended to apply the
pulsatile LVAD or, when the continuous LVAD was applied, control the device with
pulsatile control profile (with counter-pulsation) [12] to the patients with high-risk
of ventricular arrhythmias. However, considering the limitations of the current study
(the experimental cases were very limited, the measurements were performed for
only 3 h after beginning the LVAD operation, the animals were under anesthesia dur-
ing the measurements, and the mechanism of ventricular arrhythmia during LVAD
support is complicated), further long-term investigations of the clinical efficacy of
LVAD counter-pulsation control are required [27].
In this study, the v-ECG signal was measured by attaching a unipolar electrode dir-
ectly to the LV apex. This v-ECG signal is affected by changes in the local ion concen-
tration at the LV apex and thus differs from the conventional ECG signal, which is
affected by changes in the ion concentration of the whole heart tissue. However, abnor-
mal depolarization of the local ventricular muscle occurs occasionally due to the un-
stable noise caused by the mechanical stress on the heart muscle. In these exceptional
situations, counter-pulsation control based on the v-ECG signal can be temporarily un-
stable. However, the risk of this occasional instability in v-ECG-based counter-
pulsation control may not be serious because the frequency of abnormal ventricular
muscle depolarization is very low. Indeed, even when such an exceptional case occurs,
the pacing of the LVAD returns to the normal counter-pulsation operation immediately
following the next cardiac contraction. However, it is important to investigate possible
clinical situations in which the v-ECG-based counter-pulsation control becomes un-
stable and to establish additional error-correction protocols to prevent device malfunc-
tion in such abnormal situations.Conclusions
Our findings suggest that counter-pulsation control of the pulsatile LVAD can reduce
severe cardiac load variations and stabilize the blood pumping of the native heart.
However, the average working load is not markedly affected by application of counter-
pulsation control because it is also influenced by temporary cardiac outflow variations.
Based on these results, we expect counter-pulsation control of the pulsatile LVAD to
improve the long-term safety of patients with heart failure; however, more long-term
survival cases or clinical studies are required to confirm our results.
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